Here are five facts:
1. Sales are up 41 percent.
2. Revenue in the United States increased 52 percent.
3. In the first half of 2015, 3,716 PediGuard units were sold, compared to 3,008 units in the first half of 2014.
4. Gross margin of 86.1 percent is up from last year’s 85.6 percent.
5. The company’s net loss was reduced.
More articles on devices:
Conventus Orthopaedics’ promixal radius system receives FDA approval: 4 takeaways
4 key notes on Histogenics & Collagen Solutions’ supply agreement
Life Spine receives 100th patent: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
